A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease
Public ClinicalTrials.gov record NCT06225973. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Multicenter, Randomized, Double-masked Vehicle-controlled Study to Evaluate the Efficacy and Safety of TL-925 Ophthalmic Emulsion 0.1% in Subjects With Moderate to Severe Dry Eye Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
In this prospective, phase 2b, multicenter, randomized, double-masked, vehicle-controlled, parallel-arm study, approximately 880 subjects with moderate to severe dry eye disease (DED) will be randomly assigned (1:1) to receive either TL-925 or vehicle as topical ophthalmic eye drops administered bilaterally BID. The study will comprise two phases: a two-week screening phase/run-in and a six-week double-masked treatment phase.
Study identification
- NCT ID
- NCT06225973
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 880 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 5, 2024
- Primary completion
- Nov 30, 2024
- Completion
- Nov 30, 2024
- Last update posted
- Jul 9, 2024
2024
United States locations
- U.S. sites
- 18
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cornea and Cataract Consultants of Arizona | Phoenix | Arizona | 85032 | — |
| Global Research Management | Glendale | California | 91204 | — |
| Nvision - La Mesa | La Mesa | California | 91942 | — |
| Nvision - Torrance | Torrance | California | 90505 | — |
| Wyse Eyecare | Northbrook | Illinois | 60062 | — |
| Pankratz Eye | Columbus | Indiana | 47203 | — |
| Butchertown Clinical | Louisville | Kentucky | 40206 | — |
| Andover Eye Associates - Andover | Andover | Massachusetts | 01810 | — |
| Andover Eye Associates - Raynham | Raynham | Massachusetts | 02767 | — |
| NEERA - Westborough | Westborough | Massachusetts | 01581 | — |
| NEERA - Woburn | Woburn | Massachusetts | 01801 | — |
| Oculus Research | Garner | North Carolina | 27529 | — |
| Wilmington Eye | Leland | North Carolina | 28451 | — |
| Scott and Christie EyeCare Associates | Cranberry Township | Pennsylvania | 16066 | — |
| Advancing Vision Research | Goodlettsville | Tennessee | 37072 | — |
| Total Eye Care, PA | Memphis | Tennessee | 38119 | — |
| Advancing Vision Research | Smyrna | Tennessee | 37167 | — |
| Piedmont Eye Center | Lynchburg | Virginia | 24502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Dry Eye Disease trials
Other public records listing Dry Eye Disease. Sorted by last update posted; newest first. Not a recommendation.
- NCT07284381: A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease Active, not recruiting
- NCT07025811: A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment Active, not recruiting
- NCT04946721: 2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD Recruiting
- NCT06064071: Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06225973, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 9, 2024 · Synced Jul 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06225973 live on ClinicalTrials.gov.